Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain

ABSTRACT Background Data from the sentinel surveillance system of severe acute respiratory infections in Spain were used to estimate the impact of administration of nirsevimab to children born from 1 April 2023 onwards. Methods Estimated RSV hospitalisations in

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Influenza and other respiratory viruses 2024-05, Vol.18 (5), p.e13294-n/a
Hauptverfasser:	Mazagatos, Clara, Mendioroz, Jacobo, Rumayor, Mercedes Belén, Gallardo García, Virtudes, Álvarez Río, Virginia, Cebollada Gracia, Ana Delia, Batalla Rebollo, Noa, Barranco Boada, María Isabel, Pérez‐Martínez, Olaia, Lameiras Azevedo, Ana Sofía, López González‐Coviella, Nieves, Castrillejo, Daniel, Fernández Ibáñez, Ana, Giménez Duran, Jaume, Ramírez Córcoles, Cristina, Ramos Marín, Violeta, Larrauri, Amparo, Monge, Susana, Basile, Luca, García Comas, Luis, Lorusso, Nicola, Pacheco Martínez, María del Carmen, Rodríguez Martí, Cristina, Linares Dópido, Juan Antonio, Sánchez‐Migallon Naranjo, Alonso, Otero‐Barrós, María Teresa, Lopez Torrijos, Miriam, Rivas Wagner, Eva, Hermoso Castro, Luisa F., Huerta Huerta, Marta, Reina Prieto, Jorge, Gómez Juárez, Ana, Ruiz Nuñez, Aranzazu, González Carril, Fernando, Imaz Goienetxea, Liher, Ibáñez Pérez, Ana Carmen, Berradre Saenz, Belén, Puma Olguin, Tania, Pérez Gimeno, Gloria, Galindo Carretero, Silvia, Vega Piris, Lorena, Lozano, Marcos
Format:	Artikel
Sprache:	eng
Schlagworte:	Age groups Antibodies Antibodies, Monoclonal, Humanized - therapeutic use Antiviral Agents - therapeutic use Babies burden Child care Childrens health Disease prevention Epidemiology Female Health care policy Health surveillance Hospitalization Hospitalization - statistics & numerical data Humans impact Incidence Infant Infant, Newborn Infections Male Newborn babies Pandemics Pediatrics Public health respiratory infections respiratory syncitial virus Respiratory syncytial virus Respiratory Syncytial Virus Infections - drug therapy Respiratory Syncytial Virus Infections - epidemiology Respiratory Syncytial Virus, Human Respiratory tract infection SARI Seasons Sentinel Surveillance Short Communication Short Communications Spain - epidemiology surveillance Surveillance systems
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	ABSTRACT Background Data from the sentinel surveillance system of severe acute respiratory infections in Spain were used to estimate the impact of administration of nirsevimab to children born from 1 April 2023 onwards. Methods Estimated RSV hospitalisations in
ISSN:	1750-2640 1750-2659 1750-2659
DOI:	10.1111/irv.13294